IN-DATE
PRO245: AtriCure AtriClip PRO2 LAA Exclusion System, 45mm (No Box)
Sign in to add this product to your favorites!
| Price: | $2,989.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 5 eaches |
| Expiration: | 07-2026 (or later) |
| Express: | Need it tomorrow? Order in next 5 hours 31 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
Related Items
QUICK VIEW
| PRO135 - Size: 35.00mm $2,489.00 EACH AtriCure AtriClip PRO LAA Exclusion System, 35mm (No Box) Exp: 03-2026 Units in stock: 1 | Order Qty |
|
QUICK VIEW
| PRO240 - Size: 40.00mm $2,999.00 per box of 1 AtriCure AtriClip PRO2 LAA Exclusion System, 40mm Exp: 09-2026 Units in stock: 3 box of 1 | Order Qty |
|
QUICK VIEW
| PRO250 - Size: 50.00mm $2,999.00 per box of 1 AtriCure AtriClip PRO2 LAA Exclusion System, 50mm Exp: 04-2026 (or later) Units in stock: 4 box of 1 | Order Qty |
QUICK VIEW
| ACHV45-SD - Size: 45.00mm $999.99 per box of 1 AtriCure AtriClip Flex V LAA Device 45mm Exp: 10-2025 Units in stock: 1 box of 1 | Order Qty |
QUICK VIEW
| ACHV45 - Size: 45.00mm $1,790.00 EACH AtriCure AtriClip Flex V LAA Device 45mm (No Box) Exp: 04-2026 Units in stock: 1 | Order Qty |
Additional Details
AtriCure AtriClip PRO2 LAA Exclusion System
The AtriClip LAA Exclusion System is indicated for the exclusion of the heart’s left atrial appendage, performed under direct visualization and in conjunction with other cardiac surgical procedures.
LAA Exclusion System
- Hoopless End Effector
- Small Diameter End Effector (12mm)
- Active Articulation Levers
Manufacturer
AtriCure is a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions. Electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. The Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. The AtriClip Left Atrial Appendage Exclusion System products are the most widely used LAA management devices worldwide. The Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients, and the cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures.
